vs
空气化工产品公司（APD）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
空气化工产品公司的季度营收约是ROGERS CORP的15.4倍（$3.1B vs $201.5M）。空气化工产品公司净利率更高（21.9% vs 2.3%，领先19.6%）。空气化工产品公司同比增速更快（5.8% vs 4.8%）。ROGERS CORP自由现金流更多（$42.2M vs $-350.5M）。过去两年空气化工产品公司的营收复合增速更高（2.9% vs -2.8%）
空气化工产品公司是全球知名的工业气体供应商，业务覆盖全球各地，主营大气气体、工艺气体、特种气体、相关设备及服务，产品涵盖氧气、氮气、氩气、氢气、氦气、二氧化碳、一氧化碳、合成气等，同时供应空分装置、非低温发生器等气体生产处理设备，服务炼油、化工、气化等多个行业领域。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
APD vs ROG — 直观对比
营收规模更大
APD
是对方的15.4倍
$201.5M
营收增速更快
APD
高出1.0%
4.8%
净利率更高
APD
高出19.6%
2.3%
自由现金流更多
ROG
多$392.7M
$-350.5M
两年增速更快
APD
近两年复合增速
-2.8%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $3.1B | $201.5M |
| 净利润 | $678.2M | $4.6M |
| 毛利率 | 32.1% | 31.5% |
| 营业利润率 | 23.7% | 3.5% |
| 净利率 | 21.9% | 2.3% |
| 营收同比 | 5.8% | 4.8% |
| 净利润同比 | 9.8% | 1020.0% |
| 每股收益（稀释后） | $3.04 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APDROG
| Q4 25 | $3.1B | $201.5M | ||
| Q3 25 | $3.2B | $216.0M | ||
| Q2 25 | $3.0B | $202.8M | ||
| Q1 25 | $2.9B | $190.5M | ||
| Q4 24 | $2.9B | $192.2M | ||
| Q3 24 | $3.2B | $210.3M | ||
| Q2 24 | $3.0B | $214.2M | ||
| Q1 24 | $2.9B | $213.4M |
净利润APDROG
| Q4 25 | $678.2M | $4.6M | ||
| Q3 25 | $4.9M | $8.6M | ||
| Q2 25 | $713.8M | $-73.6M | ||
| Q1 25 | $-1.7B | $-1.4M | ||
| Q4 24 | $617.4M | $-500.0K | ||
| Q3 24 | $1.9B | $10.7M | ||
| Q2 24 | $696.6M | $8.1M | ||
| Q1 24 | $572.4M | $7.8M |
毛利率APDROG
| Q4 25 | 32.1% | 31.5% | ||
| Q3 25 | 32.3% | 33.5% | ||
| Q2 25 | 32.5% | 31.6% | ||
| Q1 25 | 29.6% | 29.9% | ||
| Q4 24 | 31.2% | 32.1% | ||
| Q3 24 | 34.0% | 35.2% | ||
| Q2 24 | 32.8% | 34.1% | ||
| Q1 24 | 32.0% | 32.0% |
营业利润率APDROG
| Q4 25 | 23.7% | 3.5% | ||
| Q3 25 | 0.5% | 7.3% | ||
| Q2 25 | 26.2% | -33.3% | ||
| Q1 25 | -79.8% | -0.2% | ||
| Q4 24 | 22.0% | -6.6% | ||
| Q3 24 | 76.1% | 6.9% | ||
| Q2 24 | 24.7% | 5.3% | ||
| Q1 24 | 21.7% | 5.5% |
净利率APDROG
| Q4 25 | 21.9% | 2.3% | ||
| Q3 25 | 0.2% | 4.0% | ||
| Q2 25 | 23.6% | -36.3% | ||
| Q1 25 | -59.3% | -0.7% | ||
| Q4 24 | 21.1% | -0.3% | ||
| Q3 24 | 61.2% | 5.1% | ||
| Q2 24 | 23.3% | 3.8% | ||
| Q1 24 | 19.5% | 3.7% |
每股收益（稀释后）APDROG
| Q4 25 | $3.04 | $0.20 | ||
| Q3 25 | $0.03 | $0.48 | ||
| Q2 25 | $3.20 | $-4.00 | ||
| Q1 25 | $-7.77 | $-0.08 | ||
| Q4 24 | $2.77 | $-0.04 | ||
| Q3 24 | $8.75 | $0.58 | ||
| Q2 24 | $3.13 | $0.44 | ||
| Q1 24 | $2.57 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $197.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.4B | $1.2B |
| 总资产 | $41.2B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APDROG
| Q4 25 | $1.0B | $197.0M | ||
| Q3 25 | $1.9B | $167.8M | ||
| Q2 25 | $2.3B | $157.2M | ||
| Q1 25 | $1.6B | $175.6M | ||
| Q4 24 | $2.0B | $159.8M | ||
| Q3 24 | $3.0B | $146.4M | ||
| Q2 24 | $2.4B | $119.9M | ||
| Q1 24 | $2.6B | $116.9M |
股东权益APDROG
| Q4 25 | $15.4B | $1.2B | ||
| Q3 25 | $15.0B | $1.2B | ||
| Q2 25 | $15.5B | $1.2B | ||
| Q1 25 | $14.7B | $1.3B | ||
| Q4 24 | $16.7B | $1.3B | ||
| Q3 24 | $17.0B | $1.3B | ||
| Q2 24 | $15.1B | $1.3B | ||
| Q1 24 | $14.9B | $1.3B |
总资产APDROG
| Q4 25 | $41.2B | $1.4B | ||
| Q3 25 | $41.1B | $1.4B | ||
| Q2 25 | $41.7B | $1.5B | ||
| Q1 25 | $38.9B | $1.5B | ||
| Q4 24 | $40.0B | $1.5B | ||
| Q3 24 | $39.6B | $1.5B | ||
| Q2 24 | $37.0B | $1.5B | ||
| Q1 24 | $35.9B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $900.7M | $46.9M |
| 自由现金流经营现金流 - 资本支出 | $-350.5M | $42.2M |
| 自由现金流率自由现金流/营收 | -11.3% | 20.9% |
| 资本支出强度资本支出/营收 | 40.3% | 2.3% |
| 现金转化率经营现金流/净利润 | 1.33× | 10.20× |
| 过去12个月自由现金流最近4个季度 | — | $71.1M |
8季度趋势，按日历期对齐
经营现金流APDROG
| Q4 25 | $900.7M | $46.9M | ||
| Q3 25 | — | $28.9M | ||
| Q2 25 | $855.8M | $13.7M | ||
| Q1 25 | $328.1M | $11.7M | ||
| Q4 24 | $811.7M | $33.7M | ||
| Q3 24 | — | $42.4M | ||
| Q2 24 | $1.3B | $22.9M | ||
| Q1 24 | $801.7M | $28.1M |
自由现金流APDROG
| Q4 25 | $-350.5M | $42.2M | ||
| Q3 25 | — | $21.2M | ||
| Q2 25 | $-640.0M | $5.6M | ||
| Q1 25 | $-1.6B | $2.1M | ||
| Q4 24 | $-1.3B | $18.3M | ||
| Q3 24 | — | $25.2M | ||
| Q2 24 | $-345.2M | $8.8M | ||
| Q1 24 | $-867.7M | $18.7M |
自由现金流率APDROG
| Q4 25 | -11.3% | 20.9% | ||
| Q3 25 | — | 9.8% | ||
| Q2 25 | -21.2% | 2.8% | ||
| Q1 25 | -53.6% | 1.1% | ||
| Q4 24 | -44.5% | 9.5% | ||
| Q3 24 | — | 12.0% | ||
| Q2 24 | -11.6% | 4.1% | ||
| Q1 24 | -29.6% | 8.8% |
资本支出强度APDROG
| Q4 25 | 40.3% | 2.3% | ||
| Q3 25 | 47.9% | 3.6% | ||
| Q2 25 | 49.5% | 4.0% | ||
| Q1 25 | 64.9% | 5.0% | ||
| Q4 24 | 72.2% | 8.0% | ||
| Q3 24 | 65.1% | 8.2% | ||
| Q2 24 | 53.8% | 6.6% | ||
| Q1 24 | 57.0% | 4.4% |
现金转化率APDROG
| Q4 25 | 1.33× | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | 1.20× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | 1.81× | 2.83× | ||
| Q1 24 | 1.40× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APD
| Other | $1.6B | 53% |
| Onsite | $783.9M | 25% |
| Merchant | $557.8M | 18% |
| Saleof Equipment | $117.0M | 4% |
ROG
| Elastomeric Material Solutions | $80.5M | 40% |
| Transferred At Point In Time | $69.7M | 35% |
| Transferred Over Time | $47.6M | 24% |
